VISIOPHARM A/S: Financial statements 2020
CVR: 26186676
Source: annual report 2020, Danish Business Authority
01/10/2019 – 30/09/2020
VISIOPHARM A/S (CVR 26186676) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 84,262,000 and a net result of DKK -26,308,000 compared with DKK 21,686,000 the year before. That is a decrease of 4.2% compared with the year before. The profit margin was -31.2%. Equity in the 2020 report amounted to DKK 100,466,000. The solvency ratio was 65.2%.
- Revenue
- DKK 84,262,000
- Gross Profit
- DKK 44,546,000
- Profit/Loss
- DKK -26,308,000
- Equity
- DKK 100,466,000
- Total Assets
- DKK 154,187,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 84.3M | 44.5M | -26.3M | 100.5M | - |
| 2019 | 87.9M | 33.7M | 21.7M | 77.1M | - |
| 2018 | 56.2M | 22.2M | -12M | 99.3M | - |
| 2017 | 27.2M | 21.4M | -206K | 22.7M | 37 |
| 2016 | - | 15.8M | -628K | 13.2M | - |
Official annual report
How creditworthy is VISIOPHARM A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
VISIOPHARM A/S has published its annual report for 2019. Revenue came to DKK 87,920,000, and the net result was DKK 21,686,000.
About VISIOPHARM A/S
VISIOPHARM A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2001. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named VISIOPHARM ApS. The management consists of Johan Doré Hansen and Michael Grunkin. The board consists of Evis Hursever (chair), Andrew James Thomson and Per Fredrik Thorell. The company is owned by Neptune Denmark Holdco ApS. The company has 56 employees (2026). In 2025, the company reported revenue of DKK 130,617,000 and a net result of DKK -17,223,000 compared with DKK -17,363,000 the year before. Equity in the 2025 report amounted to DKK -4,949,000.